Table 2.
Approved agents in FGFR2-positive cholangiocarcinoma.
| Agent | Company | Approval |
|---|---|---|
| Pemigatinib | Incyte | FDA |
| Infigratinib | Novartis/QED | FDA EMA |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.